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Introduction: Inﬂammatory bowel disease (IBD) is characterized by a chronic inﬂammation
of  the gastrointestinal tract, without speciﬁc cause or pathogen.
Objective: The effect of mesalazine in a colitis model induced by acetic acid (AA) was evalu-
ated.
Methods: We  used 40 Wistar rats, ±350 g, divided into 4 groups: control (CO); con-
trol + mesalazine (CO + M); colitis (CL) and colitis + M (CL + M) at 24 and 48 h of treatment.
The animals received the substances by an intracolonic enema of AA 4% and treatment
with mesalazine PO 20 mg/kg after colitis induction.
Results: Mesalazine reduced tissue damage in the gut, normalized sphincter anal pressure
levels and decreased lipid peroxidation, metabolites of nitric oxide and iNOS and NF-kB
expression in the treated groups in both treatment time points (24 and 48 h), as well as the
activity of antioxidant enzymes.
Conclusion: Mesalazine was effective in reducing tissue damage and oxidative and inﬂam-
matory damage, restored antioxidant capacity and increased anal sphincter pressure levels,
possibly due to its antioxidant effect.© 2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. This
is  an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).∗ Corresponding author.
E-mail: nmarroni@terra.com.br (N.P. Marroni).
ttp://dx.doi.org/10.1016/j.jcol.2016.03.003
237-9363/© 2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Efeito  antioxidante  da  mesalazina  no  modelo  de  colite  experimental
induzida  por  ácido  acético
Palavras-chave:
Estresse oxidativo
Inﬂamac¸ão
Óxido nítrico
r  e  s  u  m  o
Introduc¸ão: A doenc¸a inﬂamatória intestinal (DII) caracteriza-se por uma  inﬂamac¸ão crônica
do  trato gastrointestinal sem uma causa ou patógeno especíﬁco.
Objetivo: Foi avaliado o efeito da mesalazina no modelo de colite induzida por ácido acético
(AA).
Material e métodos: Foram utilizados 40 ratos wistar, ±350 gramas, divididos em 4 grupos:
Controle (CO); Controle + Mesalasina (CO + M); Colite (CL) e Colite + M (CL + M) nos tempos de
24 e 48 horas de tratamento. Os animais foram submetidos à administrac¸ão intracolônica
por enema com soluc¸ão de AA a 4% e tratamento com mesalazina na dose oral de 20 mg/kg
após  a induc¸ão da colite.
Resultados: A mesalazina reduziu as lesões teciduais no intestino, normalizou os níveis
de  pressão anal esﬁncteriana, reduziu a lipoperoxidac¸ão, metabólitos do óxido nítrico e
expressão da iNOS e do NF-kB nos grupos tratados em ambos os tempos de tratamento (24
e  48 horas), bem como a atividade das enzimas antioxidantes.
Conclusão: A mesalazina demonstrou eﬁcácia na reduc¸ão das lesões teciduais, danos oxida-
tivos e inﬂamatórios, restabeleceu a capacidade antioxidante e aumentou os níveis de
pressão anal esﬁncteriana, possivelmente pelo seu efeito antioxidante.
©  2016 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda. Este
e´  um artigo Open Access sob uma licenc¸a CC BY-NC-ND (http://creativecommons.org/Introduction
Inﬂammatory bowel disease (IBD) is characterized by chronic
inﬂammation of the gastrointestinal tract without a speciﬁc
cause or pathogen and affects millions of people worldwide.
In recent years, there has been an increase in the number of
diagnosed cases of IBD in young people; this increase has been
accompanied by signiﬁcant progress in the investigation of its
pathophysiology.1–3
Unspeciﬁc ulcerative colitis (UUC) is included in this
classiﬁcation and is characterized by mucosal ulceration,
a submucosal inﬂammatory inﬁltrate and eventually extra-
intestinal manifestations.4–6
An uncontrolled inﬂammation in UUC is probably the result
of the interaction between genetic predisposition, changes in
the innate immune system and an exaggerated response of
adaptive immunity. The inﬂammatory inﬁltrate that occurs in
UUC possibly is due to a rupture of the colonic barrier followed
by bacterial invasion; thus, pro-inﬂammatory cytokines are
released, with the generation of free radicals and increased
production of nitric oxide (NO).7–10 These factors can cause
injury and tissue destruction.10–12
The enzyme nitric oxide synthase (NOS) is responsible
for NO synthesis, through the conversion of l-arginine and
oxygen into l-citrulline and NO. The generation of nitric
oxide (NO) is critical for vascular integrity, bowel motility
and relaxation of the anal sphincter muscle.7,8,13 The enzyme
inducible nitric oxide synthase (iNOS) has a cytostatic effect
on inhibiting enzymes containing iron and also by causing
DNA fragmentation. The synthesis of iNOS is induced by
lipopolysaccharides (LPS), free radicals or any other detectable
change in the intra- or extracellular environment, activating
the transcription of pro-inﬂammatory genes.14licenses/by-nc-nd/4.0/).
Activation of nuclear factor kappa B (NF-kB) is restricted
to areas with inﬂammatory activity of mononuclear cells
and epithelial cells in the lamina propria, an effect that
was demonstrated in animal models of inﬂammatory bowel
disease. When activated, NF-kB induces transcription of proin-
ﬂammatory genes, including interleukins (IL-1, 6, 8) and
iNOS.7
Mesalazine or 5-aminosalicylic acid (5-ASA) has chemo-
preventive effects against colorectal cancer by increasing p53
protein gene expression through epigenetic mechanisms. The
anticancer effects of mesalazine can also be mediated by its
ability to remove molecules that cause oxidative damage to
mucosa.15 Studies of Ikeda et al. suggest that mesalazine can
reduce tumor cells, but not the proliferation of normal epithe-
lial cells.16
Another mechanism of action of 5-ASA is related to its
ability to interfere with the production of pro-inﬂammatory
cytokines by inhibition of NF-kB activity, inhibiting natural
killer cells of lymphocytes and monocytes in the mucosa and
reducing the production of free radicals.17
The pathophysiology of UUC is not yet fully understood.
To date, few studies have evaluated the antioxidant effects of
5-ASA in experimental models of colitis. In view of these con-
siderations, this study aims to evaluate the antioxidant action
of mesalazine in reducing oxidative damage in an experimen-
tal model of colitis induced by acetic acid.
Material  and  methods
AnimalsProcedures with animals are in accordance with the ethical
principles deﬁned by the Ethics Committee on Animal Use
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Table 1 – Index of macroscopic and microscopic changes
in the colonic mucosa.
Scoring Microscopic analysis
0 Normal
1 Slight damage and some points of inﬂammatory
inﬁltrate in the mucosa
2 Damage and moderate inﬂammatory inﬁltrate in
two or more areas of the mucosaj coloproctol (rio j). 
 ULBRA, Canoas, RS, under the approval of this Committee
project 2015-22P), and with the guidelines of the European
nion of Animal Experimentation 86/609 EEC.18
Forty male Wistar rats weighing approximately 300 g were
sed; the animals were divided into four groups according
o the time of treatment (24 and 48 h) – control (CO) (n = 5),
ontrol + mesalazine (CO + M)  (n = 5), colitis (CL) (n = 5) and col-
tis + mesalazine (M + CL) (n = 5). The animals were kept in a
ivarium of the Universidade Luterana do Brasil, in plastic
oxes of 47 cm × 34 cm × 18 cm lined with wood shavings in a
2-h light/dark cycle (illumination from 7 to 19 h) and tem-
erature between 20 and 25 ◦C. Water and food were given
d libitum. The model chosen for the induction of colitis was
dapted from those described by Yamada et al. and Tannahill
t al.19,20 All animals were previously anesthetized and CL and
L + M groups were subjected to intracolonic administration
f a solution of acetic acid diluted to 4% and with a vol-
me  of 4 mL  by enema; and animals of CO and CO + M groups
ere submitted to the intracolonic administration of saline
.9% with a volume of 4 mL,  also by enema. The administra-
ion of mesalazine in CO + M and CL + M groups was carried
ut PO at a dose of 20 mg/kg diluted in 1 mL  of saline 0.9%,
nd the other groups received 1 mL  of saline 0,9% (adapted
rom Hirotani et al.21). The drug administered is marketed as
esacol® (Nycomed Pharma). Each tablet contains 1200 mg  of
esalazine.
After the period of treatment of each group (24 and 48 h),
he animals were anesthetized with xylazine 2% at a dose of
 mg/kg and ketamine 98 mg/kg intraperitoneally. Following
his procedure, the measurement of anal sphincter pressure
as carried out and a portion of about 8 cm of the intestine was
emoved for histological and immunohistochemical analysis
nd also for other biochemical studies. Finally, the animals
ere killed by exsanguination under deep anesthesia.18
easurement  of  anal  sphincter  pressure
fter induction of disease and treatment with mesalazine,
nimals were anesthetized with the aim of obtaining
nal sphincter pressures. An anorectal manometry device
Proctossystem-Viotti – SP) with a balloon catheter and mea-
urements in cm H2O was used. The balloon catheter was
ntroduced into the anal canal and then retracted, so as to
ecord the sphincter pressure. Three sequential measure-
ents were performed and then the average of the three
alues was obtained, in order to obtain the result of pressure.22
istological  analysis
n histological study, a fragment of the intestine was immersed
n buffered formalin. Then the fragment was embedded in
arafﬁn blocks and sectioned on a rotary microtome (thick-
ess, 3 m).  The sections were stained in hematoxylin–eosin
HE) for routine histologic evaluation. The slides were ana-
yzed under a NIKON Labophot binocular microscope (200×
agniﬁcation). The histological analysis was based on the
resence of inﬂammatory inﬁltrate, edema, necrosis accord-
ng to the damage index shown in Table 1 and adapted from
illar et al.233 Damage and severe inﬂammatory inﬁltrate in the
mucosa with loss of epithelium
Lipid  peroxidation
Samples of bowel tissue were placed in test tubes with a mix-
ture of trichloroacetic acid (TCA) 10% and thiobarbituric acid
(TBA) 0.67%. Subsequently, the samples were heated in a water
bath for 15 min  and cooled on ice for approximately 5 min.
TBA reacts with lipid peroxidation products forming a Schiff
base; TCA is used to denature proteins present in the mixture,
as well as to acidify the reaction. After cooling the samples,
1.5 mL  of n-butyl alcohol was added to extract the formed
pigment. The samples were placed on a stirrer for 45 s and
centrifuged for 10 min  at 3000 rpm. Finally, the stained product
present in the supernatant was read on a spectrophotometer
at a wavelength of 535 nm.  The TBARS concentration obtained
was expressed in nmol per milligram of protein.24
Activity  of  antioxidant  enzymes  superoxide  dismutase
(SOD) and  glutathione  peroxidase  (GPx)
The activity of the enzyme superoxide dismutase (SOD) is
deﬁned by its ability to inhibit a detection system which
reacts with superoxide radical. The SOD measurement tech-
nique is based on the inhibition of this reaction. To that
end, adrenaline was used; when in an alkaline medium, this
substance becomes adrenochrome, yielding O− which is the
enzyme substrate; thus, its deﬁnition occurs by the amount
of SOD, which has the ability to inhibit by 50% the rate of
oxidation of the detector adrenaline.25
This enzyme catalyzes the reaction of hydroperoxide with
reduced glutathione (GSH) to form oxidized glutathione (GSSG)
and the product from hydroperoxide reduction.
GPx activity can be studied by measuring the rate of NADPH
consumption in a system containing GSH in the presence of
glutathione reductase (GR). The technique consists of deter-
mining the spectrophotometric activity of the enzyme, by
measuring the rate of NADPH oxidation in a reactive mix-
ture. GPx activity was measured in a spectrophotometer at
340 nm and expressed as nmol per minute per milligram pro-
tein (nmol/min/mg prot).26
Levels  of  nitric  oxide  metabolites  –  nitrites  and  nitrates
Nitric oxide production was measured indirectly with a col-
orimetric quantitative test using the Griess reaction. This
reaction is based on the enzymatic reduction of nitrates to
nitrites in the presence of nitrate reductase and NADPH, and
on the subsequent reaction of the nitrites formed (or ini-
tially present in the samples) with Griess reagent (a mixture
j). 2 0 1 6;3  6(3):139–148
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Fig. 1 – Effect of mesalazine in bowel macroscopic changes
in an experimental model of colitis.
CO, control; CO + M,  control + mesalazine, CL, colitis; CL + M,
colitis + mesalazine; CP, crypts; E, edema; SB, submucosa.
a Signiﬁcant difference between CL and CO/CO + M.142  j coloproctol (rio 
of sulfanilamide and naphthylethylenediamine speciﬁc for
NO2−). The reading was performed in a microplate reader at
540 nm and the results were expressed in mmol  of NO2/NO3.27
Immunohistochemistry  of  the  enzyme  inducible  nitric
oxide synthase  (iNOS)  and  nuclear  factor  kappa  B  (NF-kB)
For immunohistochemistry, the bowel samples were incu-
bated with 10% of rabbit serum at room temperature for
blocking possible undesired reactions of the secondary anti-
body. Slides were incubated with rabbit polyclonal antibodies
against iNOS and NF-kB (iNOS and NF-kB: Santa Cruz Biotech-
nology, United States) in a dilution of 1:200 overnight at 4 ◦C.
After this period, the solution with the primary antibody
was removed, the slides were washed in buffer and further
incubated with the secondary antibody (biotinylated anti-
rabbit IgG, Santa Cruz Biotechnology, Santa Cruz, CA, USA)
for 30 min  at room temperature. Next, the secondary anti-
body was removed and afterward the samples were treated
with EnVision reagent and then washed three times with
buffer. Nuclei were counterstained with hematoxylin. Finally,
the slides were washed two times with ethanol and xylene for
10 s.
The images were photographed through a microscope
equipped with a digital camera in order to capture images
using the software Image-Plus (Media Cybernetics, Bethesda,
USA); this done, the expression of iNOS and NF-kB was car-
ried out by digital analysis by Adobe Photoshop® software
CS3 extended, version 10.0, by counting all pixels stained
by the immunohistochemistry reaction. The level of protein
expression (iNOS and NF-kB) was determined by multiply-
ing the average density of the image  by the percentage of
those areas positively stained by the antibodies (brown stain-
ing areas).
Statistical  analysis
From the collected data, the means and standard devia-
tions of each group were calculated using the statistical
software GrapPad INSTAT, version 3.0. The test used for anal-
ysis of variance of the results was ANOVA, followed by the
Student–Newman–Keuls test for parametric data. The results
were considered statistically signiﬁcant when a signiﬁcance
level of at least 5% (p < 0.05) was obtained.
Results
Histological  analysis
Through the histological analysis, we  found that the animals
in CL group showed the destruction of crypts (CP) and edema
of the submucosa (SB) in the animals’ intestine. No histologi-
cal changes were found in CO and CO + M groups. The groups
treated with mesalazine – M + CL (24 and 48 h) showed preser-
vation of CP and a decrease of submucosal edema. The results
of microscopic damage indexes showed less damage in the
treated groups – CL + M in both times (24 and 48 h) (Fig. 1A and
B) when compared to colitis group.b Signiﬁcant difference between CL + M and CL.
Anal  sphincter  pressure
The sphincter anal pressure results showed a signiﬁcant
decrease in colitis group and a signiﬁcant increase in groups
treated with mesalazine in both treatment times (24 and 48 h)
versus colitis group (p < 0.001) (Fig. 2A and B).
Lipid  peroxidation
The results of lipid peroxidation (LPO) using the technique of
substances that react with the presence of thiobarbituric acid
(TBARS) showed a signiﬁcant increase in LPO in LC group versus
CO and CO + M groups, and a signiﬁcant reduction in LPO in
j coloproctol (rio j). 2 0 1 6;3 6(3):139–148 143
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Fig. 2 – Effect of mesalazine in the levels of anal sphincter
pressure in an experimental model of colitis. The results
correspond to mean ± standard error (SE).
CO, control; CO + M,  control + mesalazine; CL, colitis; CL + M,
colitis + mesalazine.
Anal sphincter pressure at 24 and 48 h.
a Signiﬁcant difference between CL and CO/CO + M.
b Signiﬁcant difference between CL + M and CL.
Table 2 – Effect of mesalazine in the levels of lipid
peroxidation (LPO) and activity of antioxidant enzymes
superoxide dismutase (SOD) and glutathione peroxidase
(GPx) in an experimental model induced by acetic acid.
The results correspond to mean ± standard error (SE).
Groups 24 h
LPO SOD GPx
CO 0.26 ± 0.03 4.96 ± 1.40 0.27 ± 0.03
CO + M 0.22 ± 0.03 3.66 ± 0.76 0.25 ± 0.02
CL 0.87 ± 0.05a 14.35 ± 2.68a 0.16 ± 0.01a
CL + M 0.44 ± 0.05b 10.00 ± 1.54b 0.23 ± 0.01b
Groups 48 h
LPO SOD GPx
CO 0.27 ± 0.05 0.57 ± 0.15 0.58 ± 0.09
CO + M 0.30 ± 0.01 0.72 ± 0.17 0.51 ± 0.06
CL 0.66 ± 0.08a 2.83 ± 1.18a 0.23 ± 0.03a
CL + M 0.49 ± 0.05b 1.05 ± 0.26b 0.46 ± 0.04b
LPO 24 h (p < 0.001); 48 h (p < 0.05). SOD 24 and 48 h (p < 0.05). GPx 24
and 48 h (p < 0.05).
CO, control; CO + M, control + mesalazine; CL, colitis; CL + M, coli-
tis + mesalazine.
a Signiﬁcant difference between CL and CO/CO + M.
b Signiﬁcant difference between CL + M and CL.
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Fig. 3 – Effect of mesalazine in the levels of NO metabolites
in an experimental model of colitis. The results correspond
to mean ± standard error (SE).
CO, control; CO + M,  control + mesalazine; CL, colitis; CL + M,
colitis + mesalazine.
NO at 24 and 48 h (p < 0.001).
a Signiﬁcant difference between CL and CO/CO + M.
b Signiﬁcant difference between CL + M and CL.groups treated with mesalazine in both treatment times (24
and 48 h) versus CL group (Table 2A – p < 0.001; B – p < 0.05).
Activity  of  antioxidant  enzymes  superoxide  dismutase
(SOD) and  glutathione  peroxidase  (GPx)
A signiﬁcant increase in the activity of antioxidant enzyme
SOD in both treatment times (24 and 48 h) was observed in
the LC group versus CO and CO + M groups, and a signif-
icant reduction in CL + M group versus SC group (Table 2A
and B – p < 0.05). A signiﬁcant decrease in the activity of GPx
enzyme in both treatment times (24 and 48 h) was observed
in the LC group versus CO and CO + M groups, and a signiﬁ-
cant increase in CL + M group versus CL group (Table 2A; B –
p < 0.05).
Levels  of  nitric  oxide  metabolites  –  nitrites  and  nitratesThe levels of nitric oxide metabolites (nitrites and nitrates)
in both treatment times (24 and 48 h) showed a signiﬁcant
increase in the LC group versus CO and CO + M groups and a
signiﬁcant decrease in CL + M group versus CL group (Fig. 3A
and B – p < 0.01).
j). 2 0144  j coloproctol (rio 
Immunohistochemistry  and  quantiﬁcation  of  iNOS  and
NF-kB
The CL animals in both treatment times (24 and 48 h) showed
a strong positive staining for iNOS and NF-kB which was noted
by the brown staining. CO and CO + M groups showed no pos-
itive staining. The treatment with mesalazine diminished the
staining for iNOS and NF-kB. Likewise, in the quantiﬁcation of
the expression of iNOS and NF-kB, a signiﬁcant decrease in the
CL + M group was observed, compared to CL group. All images
are featured in 200× magniﬁcation (Fig. 4A and B and Fig. 5A
and B – p < 0.001).
Discussion
The pathophysiology of ulcerative colitis is not yet fully under-
stood; thus, the study with experimental models can help to
determine the factors involved in this disease, also allowing
the study of therapeutic agents in order to achieve more  effec-
tive treatments. Colitis induced by acetic acid enema have
similarities with UUC in humans with respect to histological
and metabolic features, promoting the development of sub-
mucosal edema, inﬂammatory inﬁltrate, colonic ulceration,
destruction of crypts and depletion of goblet cells. Considering
that the model evaluates acute characteristics, one can inves-
tigate the components involved in inﬂammation and evaluate
the effectiveness of new therapies in the acute phase of the
disease.7,28
The histological analysis demonstrated the trophic effect of
mesalazine in the colon, improving the colonic structure and
decreasing the size and severity of the injury. In the treated
groups (24 and 48 h) an initial injury was observed where the
antioxidant action of mesalazine led to the preservation of
the mucosa since its apical part still had some mucosal lesions
and its basal part was intact. In their study, Song et al. demon-
strated that the concomitant administration of butyrate and
mesalazine in a model of experimental colitis induced by
dextran sulfate sodium (DSS) improved colonic injury, the
inﬂammatory proﬁle of the mucosa and cecal lymph node.
Normalization of neutrophil, eosinophil and activated B and T
lymphocytes inﬁltrate was observed, highlighting the poten-
tial use of butyrate as an adjunct in the treatment of UUC.29,30
In experimental trials, 5-ASA was administered in combi-
nation with NAC (N-acetylcysteine) in rats with TNBS-(2,4,6-
trinitrobenzene sulfonic acid) induced colitis, and it was found
that the combined treatment showed synergism versus single-
agent treatment, promoting repair of inﬂamed mucosa.4
Among the factors related to UUC, one can describe the
inﬁltration of neutrophils due to their ability to release RL
and proinﬂammatory cytokines with the increase of LPO.13 On
the other hand, oxidative stress has its damage minimized by
antioxidant defenses of endogenous or exogenous nature. In
their study, Harris et al. demonstrated that RL plays an impor-
tant role in the pathogenesis assigned to LPO present in cell
membranes. Biopsies performed in patients with UUC Showed
high LPO index versus normal subjects.31
In our study, we observed that mesalazine decreased LPO
in treated animals (24 and 48 h), similar to the control group
ﬁndings, possibly by its antioxidant action. Similar results 1 6;3  6(3):139–148
were found in contemporary studies that used substances
with antioxidant action as glutamine, melatonin, Boswellia ser-
rata and quince extract in experimental models of ulcerative
colitis.7,13,28
Oxidative stress has its damage minimized by non-
enzymatic antioxidant defense systems, such as vitamins
and/or enzymes. In our study, we  observed in colitis group
an increase of SOD in response to the increase of LPO due
to oxidative stress, and a reduction in these parameters in
both groups treated with mesalamine (24 and 48 h). GPx activ-
ity was decreased in colitis group and increased in those
groups treated (24 and 48 h). Our results show that mesalazine
increased enzyme activity in treated groups, conﬁrming its
action on oxidative stress. Our results corroborate the study of
Arab et al. that evaluated the activity of antioxidant enzymes
SOD and GPx in an experimental model of TNBS-induced col-
itis. After treatment with telmisartan, a signiﬁcant increase
was demonstrated in the activity of SOD and GPx; this out-
come highlights the antioxidant effects of these treatments.12
The implication of oxidative stress in the pathogenesis of UUC
has been emphasized by several clinical and experimental
studies, where the generation of RL and NO is related to intesti-
nal lesions.10,11,13 in this study, the levels of anal sphincter
pressure, as a physiological parameter of nitric oxide activity,
were measured. The results conﬁrm a signiﬁcant decrease in
anal sphincter pressure measurements in animals of the col-
itis group, and a signiﬁcant increase in NO levels. The groups
treated with mesalamine (24 and 48 h) showed an increase in
anal sphincter pressure and a signiﬁcant reduction in NO lev-
els, compared to what was found in colitis group animals.
Experimental animal studies indicate that nitric oxide and
vasoactive intestinal polypeptide have an inhibitory action on
smooth muscle, promoting relaxation of the anal sphincter,
thus decreasing anal sphincter pressure levels.7,8,13
Our results corroborate those of Hartmann et al. who
demonstrated a signiﬁcant increase in nitric oxide levels in the
intestine of animals with colitis and a consequent decrease in
anal sphincter pressure levels in colitis group animals, sug-
gesting the involvement of relaxation of sphincter muscle
with increasing nitric oxide levels. Fillmann et al. observed
an increase in nitric oxide levels and a decrease in sphinc-
ter anal pressure levels in animals with induced colitis; and
when these animals were treated with the antioxidant glu-
tamine, these authors observed a signiﬁcant decrease of nitric
oxide levels and a consequent increase in sphincter anal
pressure.7,13
Carrier et al. found that mice subjected to colitis due to
DSS showed increases in oxidative stress and in inﬂamma-
tory markers as follows:. TNF-alpha, IL-1 and NF-kB.32 Other
studies have also associated increases of NO and increases in
iNOS expression in colitis models.8,9 In our study, we  observed
increased expression of iNOS and NF-kB in colitis group ani-
mals. The group treated with mesalamine showed decreased
expression of these proteins. Similar results were found in
the study by Arab et al. who used telmisartan as therapy for
experimental colitis and observed decreased levels of NF-kB
evaluated by immunohistochemistry, besides a diminished
iNOS gene expression evaluated by PCR.12 Davaatseren et al.
used allyl isothiocyanate, an antioxidant compound found
in plants, as therapy for DSS-induced colitis and reported
j coloproctol (rio j). 2 0 1 6;3 6(3):139–148 145
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Fig. 4 – Effect of mesalazine in the expression of the enzyme inducible nitric oxide synthase (iNOS) in an experimental
model of colitis. The results correspond to mean ± standard error (SE).
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iNOS at 24 and 48 h (p < 0.001).
a Signiﬁcant difference between CL and CO/CO + M.
b Signiﬁcant difference between CL + M and CL.
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iminished iNOS expression in groups treated with vari-
us doses of this compound.3 Kretzmann et al. observed a
ecrease in the expression of p65 and p50 subunits of NF-kB
n animals treated with glutamine in the experimental model
f TNBS-induced colitis.8
Although the pathogenesis is not yet fully understood, the
reatments available have been able to intervene, improving
he quality of life of patients. Therefore, it is suggested that
esalazine determines an improvement in the inﬂammatory
owel picture, also thanks to its antioxidant action.
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